Could a herbal extract keep liver cancer away after surgery?

NCT ID NCT07328828

Ongoing Disease control Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether icaritin soft capsules, taken daily for up to a year, can help prevent liver cancer from coming back in patients who had surgery to remove their tumor. Twenty adults with high-risk features for recurrence will take the capsules twice a day. The main goal is to see how long they stay cancer-free, and the study also tracks side effects and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: icaritin soft capsules
What this could lead to: If it works, this could point toward a way to lower the chance of liver cancer coming back after surgery.
What could go wrong: This is a very early, small study with only 20 people, so results may not apply widely. The treatment is taken until recurrence or for up to a year, and side effects are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hepatocellular carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RFS

Contacts and locations

Locations

the Second Affiliated Hospital, Zhejiang University School of Medicine

Hangzhou, Zhejiang, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.